Symbol43F
NameACROMETA GROUP LIMITED
SectorUNDEFINED
RegionAsia
Industry-
Address6001 Beach Road #16-03 Golden Mile Tower Singapore 199589
Telephone65 67170111
Fax65 67431159
Email-
Websitehttp://www.acromec.com
IncorporationSINGAPORE
Incorporated On22 Dec 2015
Employees-
Fiscal Year-
Public Since-
ExchangesSGX
AuditorPKF-CAP LLP
Audit StatusNOT PROVIDED
Reporting Status
CIK
Description


Acromec Limited (“Acromec”, and together with its subsidiary, the “Group”) is a Singapore-based specialist engineering services provider in the field of controlled environments. The Group’s expertise is in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms. It provides integrated services including engineering, procurement, construction and maintenance services, specialising in architectural, mechanical, electrical and process works within controlled environments.
The Group serves mainly the healthcare, biomedical, research and academia, and electronics sectors and its customers comprise mainly hospitals and medical centres, government agencies, research and development companies or agencies, research and development units of multinational corporations, tertiary educational institutions, pharmaceutical companies, semiconductor manufacturing companies, and multinational engineering companies.
The Group’s services include design and/or construction of new facilities in new and existing buildings, refurbishment and upgrading of existing facilities and corrective and routine maintenance services. Acromec’s business is divided into two main segments: (1) Engineering, Procurement and Construction; and (2) Maintenance.
For more information, please visit Acromec’s website at www.acromec.com.

Additional info from SGX:

Acromec Limited (“Acromec”, and together with its subsidiary, the “Group”) is a Singapore-based specialist engineering services provider in the field of controlled environments. The Group’s expertise is in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms. It provides integrated services including engineering, procurement, construction and maintenance services, specialising in architectural, mechanical, electrical and process works within controlled environments.
The Group serves mainly the healthcare, biomedical, research and academia, and electronics sectors and its customers comprise mainly hospitals and medical centres, government agencies, research and development companies or agencies, research and development units of multinational corporations, tertiary educational institutions, pharmaceutical companies, semiconductor manufacturing companies, and multinational engineering companies.
The Group’s services include design and/or construction of new facilities in new and existing buildings, refurbishment and upgrading of existing facilities and corrective and routine maintenance services. Acromec’s business is divided into two main segments: (1) Engineering, Procurement and Construction; and (2) Maintenance.
For more information, please visit Acromec’s website at www.acromec.com.

2026-09-04 14:35

General Announcement: AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership with Macro

Read more
2026-09-04 14:34

General Announcement: Entry into an Indicative Term Sheet in relation to the Proposed Investment

Read more
2026-08-03 13:31

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director - Toh Ker How

Read more
2026-06-16 11:11

General Announcement: Corrigendum to the announcement dated 15 June 2026 in relation to the Record Date

Read more
2026-06-15 11:08

Outcome of Regulatory Review:

Read more
2026-06-11 13:12

General Announcement: AcroMeta Group - Launch of Zhimaos China Operations Through Strategic Cooperation in Shenzhen

Read more
2026-06-11 13:08

General Announcement: Entry into a Shareholders and Technology Licensing Agreement

Read more
2026-06-11 11:21

Outcome of Regulatory Review:

Read more
2026-06-10 15:26

General Announcement: Proposed Renounceable Non-Underwritten Rights cum Warrants Issue - Receipt of LQN

Read more
2026-06-02 10:56

General Announcement: Non-Completion of Proposed Subscription of 16,666,667 New Ordinary Shares

Read more